Would you avoid giving an IMiD in the context of newly diagnosed multiple myeloma with a recent diagnosis of a serious solid tumor like pancreatic cancer?
One particular patient received a standard risk myeloma diagnosis during adjuvant chemo for pancreas cancer. Given high mortality risk if pancreas cancer relapsed, and IMiD association with increased malignancy risk, how would you approach treatment of both?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Harvard Medical School
Answered on
Doing just a PI and antibody-based treatment would be totally reasonable. Adding an IMiD in the future, depending on how their treatment is going; one can always consider an IMiD or a cell mod later. I don't believe, though, that the addition of an IMiD will increase the risk of Ca progression. It i...
Join for free or sign in to see the full answer